Kestra Medical Technologies (KMTS) Competitors

$22.07 +0.62 (+2.89%)

Closing price 05/14/2026 04:00 PM Eastern

Extended Trading

$22.07 +0.00 (+0.00%)

As of 04:07 AM Eastern

KMTS vs. IRTC, NVST, LIVN, LQDA, and MMED

Should you buy Kestra Medical Technologies stock or one of its competitors? MarketBeat compares Kestra Medical Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kestra Medical Technologies include iRhythm Technologies (IRTC), Envista (NVST), LivaNova (LIVN), Liquidia (LQDA), and MiniMed Group (MMED). These companies are all part of the "medical equipment" industry.

How does Kestra Medical Technologies compare to iRhythm Technologies?

Kestra Medical Technologies (NASDAQ:KMTS) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk.

In the previous week, iRhythm Technologies had 4 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 5 mentions for iRhythm Technologies and 1 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 1.89 beat iRhythm Technologies' score of 1.47 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Kestra Medical Technologies	Very Positive
iRhythm Technologies	Positive

Kestra Medical Technologies has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market.

iRhythm Technologies has higher revenue and earnings than Kestra Medical Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$59.81M	21.54	-$113.81M	-$3.96	N/A
iRhythm Technologies	$747.14M	5.02	-$44.55M	-$0.86	N/A

Kestra Medical Technologies currently has a consensus target price of $27.40, indicating a potential upside of 24.15%. iRhythm Technologies has a consensus target price of $193.38, indicating a potential upside of 69.40%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93

iRhythm Technologies has a net margin of -3.53% compared to Kestra Medical Technologies' net margin of -171.87%. iRhythm Technologies' return on equity of -10.26% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

Summary

iRhythm Technologies beats Kestra Medical Technologies on 12 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Envista?

Kestra Medical Technologies (NASDAQ:KMTS) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

In the previous week, Envista had 10 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 11 mentions for Envista and 1 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 1.89 beat Envista's score of 0.56 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Kestra Medical Technologies	Very Positive
Envista	Positive

Kestra Medical Technologies has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Envista has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market.

Kestra Medical Technologies presently has a consensus price target of $27.40, indicating a potential upside of 24.15%. Envista has a consensus price target of $28.83, indicating a potential upside of 21.00%. Given Kestra Medical Technologies' higher possible upside, analysts plainly believe Kestra Medical Technologies is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Envista has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$59.81M	21.54	-$113.81M	-$3.96	N/A
Envista	$2.72B	1.43	$47M	$0.41	58.12

Envista has a net margin of 2.41% compared to Kestra Medical Technologies' net margin of -171.87%. Envista's return on equity of 7.11% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%
Envista	2.41%	7.11%	3.91%

Summary

Envista beats Kestra Medical Technologies on 10 of the 13 factors compared between the two stocks.

How does Kestra Medical Technologies compare to LivaNova?

Kestra Medical Technologies (NASDAQ:KMTS) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Kestra Medical Technologies has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

LivaNova has a net margin of 7.48% compared to Kestra Medical Technologies' net margin of -171.87%. LivaNova's return on equity of 16.48% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%
LivaNova	7.48%	16.48%	7.59%

In the previous week, LivaNova had 7 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 8 mentions for LivaNova and 1 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 1.89 beat LivaNova's score of 0.57 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Kestra Medical Technologies	Very Positive
LivaNova	Positive

97.6% of LivaNova shares are held by institutional investors. 3.6% of Kestra Medical Technologies shares are held by insiders. Comparatively, 0.4% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Kestra Medical Technologies has higher earnings, but lower revenue than LivaNova. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$59.81M	21.54	-$113.81M	-$3.96	N/A
LivaNova	$1.39B	2.84	-$242.47M	$1.95	36.75

Kestra Medical Technologies presently has a consensus price target of $27.40, indicating a potential upside of 24.15%. LivaNova has a consensus price target of $77.22, indicating a potential upside of 7.75%. Given Kestra Medical Technologies' higher probable upside, equities analysts plainly believe Kestra Medical Technologies is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
LivaNova	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

Summary

LivaNova beats Kestra Medical Technologies on 10 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Liquidia?

Liquidia (NASDAQ:LQDA) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

Liquidia has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

64.5% of Liquidia shares are held by institutional investors. 25.6% of Liquidia shares are held by insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Liquidia had 49 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 50 mentions for Liquidia and 1 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 1.89 beat Liquidia's score of 0.56 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Liquidia	Positive
Kestra Medical Technologies	Very Positive

Liquidia has a net margin of 7.74% compared to Kestra Medical Technologies' net margin of -171.87%. Liquidia's return on equity of 46.82% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Liquidia	7.74%	46.82%	7.06%
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%

Liquidia presently has a consensus price target of $49.33, indicating a potential downside of 16.81%. Kestra Medical Technologies has a consensus price target of $27.40, indicating a potential upside of 24.15%. Given Kestra Medical Technologies' higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than Liquidia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Liquidia	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	3 Strong Buy rating(s)	2.92
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Liquidia has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Liquidia	$158.32M	33.31	-$68.92M	$0.14	423.57
Kestra Medical Technologies	$59.81M	21.54	-$113.81M	-$3.96	N/A

Summary

Liquidia beats Kestra Medical Technologies on 14 of the 17 factors compared between the two stocks.

How does Kestra Medical Technologies compare to MiniMed Group?

Kestra Medical Technologies (NASDAQ:KMTS) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

19.7% of MiniMed Group shares are owned by institutional investors. 3.6% of Kestra Medical Technologies shares are owned by company insiders. Comparatively, 2.2% of MiniMed Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, MiniMed Group had 3 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 4 mentions for MiniMed Group and 1 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 1.89 beat MiniMed Group's score of 1.37 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Kestra Medical Technologies	Very Positive
MiniMed Group	Positive

MiniMed Group has a net margin of 0.00% compared to Kestra Medical Technologies' net margin of -171.87%. MiniMed Group's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%
MiniMed Group	N/A	N/A	N/A

Kestra Medical Technologies currently has a consensus price target of $27.40, indicating a potential upside of 24.15%. MiniMed Group has a consensus price target of $22.25, indicating a potential upside of 100.81%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts clearly believe MiniMed Group is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
MiniMed Group	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.93

MiniMed Group has higher revenue and earnings than Kestra Medical Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$59.81M	21.54	-$113.81M	-$3.96	N/A
MiniMed Group	$2.99B	1.04	N/A	N/A	N/A

Summary

MiniMed Group beats Kestra Medical Technologies on 10 of the 13 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KMTS vs. The Competition

Export

Metric	Kestra Medical Technologies	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.25B	$8.18B	$6.34B	$12.37B
Dividend Yield	N/A	2.53%	2.80%	5.35%
P/E Ratio	-5.57	15.80	20.66	25.63
Price / Sales	21.54	8.38	549.87	76.59
Price / Cash	N/A	16.82	43.26	56.33
Price / Book	5.52	3.63	9.93	6.97
Net Income	-$113.81M	$223.05M	$3.55B	$333.62M
7 Day Performance	4.85%	-1.07%	1.71%	1.09%
1 Month Performance	9.31%	1.86%	0.49%	3.08%
1 Year Performance	-7.07%	2.20%	39.41%	35.68%

Kestra Medical Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KMTS Kestra Medical Technologies	2.3538 of 5 stars	$22.07 +2.9%	$27.40 +24.2%	-1.5%	$1.25B	$59.81M	N/A	300	Positive News
IRTC iRhythm Technologies	4.3845 of 5 stars	$120.66 -3.4%	$193.38 +60.3%	-18.7%	$4.10B	$747.14M	N/A	2,400
NVST Envista	3.4637 of 5 stars	$24.27 -0.1%	$28.83 +18.8%	+33.1%	$3.95B	$2.72B	59.18	12,000
LIVN LivaNova	2.3221 of 5 stars	$71.86 +1.3%	$77.22 +7.5%	+64.6%	$3.90B	$1.39B	36.85	3,300
LQDA Liquidia	2.6808 of 5 stars	$42.40 +0.3%	$43.44 +2.5%	+218.0%	$3.76B	$158.32M	N/A	50	Trending News Earnings Report Analyst Forecast Insider Trade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KMTS) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. IRTC, NVST, LIVN, LQDA, and MMED

How does Kestra Medical Technologies compare to iRhythm Technologies?

Summary

How does Kestra Medical Technologies compare to Envista?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Summary

How does Kestra Medical Technologies compare to Liquidia?

Summary

How does Kestra Medical Technologies compare to MiniMed Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. IRTC, NVST, LIVN, LQDA, and MMED

How does Kestra Medical Technologies compare to iRhythm Technologies?

Does the media refer more to KMTS or IRTC?

Which has more volatility & risk, KMTS or IRTC?

Which has preferable valuation & earnings, KMTS or IRTC?

Do analysts prefer KMTS or IRTC?

Is KMTS or IRTC more profitable?

Summary

How does Kestra Medical Technologies compare to Envista?

Does the media refer more to KMTS or NVST?

Which has more volatility and risk, KMTS or NVST?

Do analysts rate KMTS or NVST?

Which has preferable valuation and earnings, KMTS or NVST?

Is KMTS or NVST more profitable?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Which has more risk and volatility, KMTS or LIVN?

Is KMTS or LIVN more profitable?

Does the media prefer KMTS or LIVN?

Do insiders & institutionals have more ownership in KMTS or LIVN?

Which has higher earnings and valuation, KMTS or LIVN?

Do analysts recommend KMTS or LIVN?

Summary

How does Kestra Medical Technologies compare to Liquidia?

Which has more risk & volatility, LQDA or KMTS?

Do institutionals & insiders have more ownership in LQDA or KMTS?

Does the media prefer LQDA or KMTS?

Is LQDA or KMTS more profitable?

Do analysts recommend LQDA or KMTS?

Which has stronger earnings & valuation, LQDA or KMTS?

Summary

How does Kestra Medical Technologies compare to MiniMed Group?

Do institutionals and insiders have more ownership in KMTS or MMED?

Does the media prefer KMTS or MMED?

Is KMTS or MMED more profitable?

Do analysts rate KMTS or MMED?

Which has better valuation and earnings, KMTS or MMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools